Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 3
1967 1
1968 3
1970 3
1971 3
1974 2
1975 2
1976 1
1979 3
1980 1
1981 1
1982 2
1983 1
1985 1
1988 2
1989 5
1990 5
1991 2
1992 5
1993 3
1994 3
1995 6
1996 8
1997 3
1998 5
1999 6
2000 7
2001 8
2002 2
2003 7
2004 6
2005 6
2006 5
2007 3
2008 7
2009 17
2010 11
2011 12
2012 17
2013 13
2014 19
2015 18
2016 15
2017 12
2018 16
2019 20
2020 31
2021 38
2022 31
2023 15
2024 19
2025 30
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

412 results

Results by year

Filters applied: . Clear all
Page 1
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Sanchorawala V, Gibbs S, Mollee P, Venner CP, Lu J, Schönland S, Gatt ME, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Huart A, Dimopoulos MA, Bhutani D, Waxman AJ, Goodman SA, Zonder JA, Lam S, Song K, Hansen T, Manier S, Roeloffzen W, Jamroziak K, Kwok F, Shimazaki C, Kim JS, Crusoe E, Ahmadi T, Tran N, Qin X, Vasey SY, Tromp B, Schecter JM, Weiss BM, Zhuang SH, Vermeulen J, Merlini G, Comenzo RL; ANDROMEDA Trial Investigators. Kastritis E, et al. N Engl J Med. 2021 Jul 1;385(1):46-58. doi: 10.1056/NEJMoa2028631. N Engl J Med. 2021. PMID: 34192431 Clinical Trial.
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.
Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JM, Musso M, Giebel S, Uzay A, Langmuir P, Hollaender N, Gowda M, Stefanelli T, Lee SJ, Teshima T, Locatelli F; REACH3 Investigators. Zeiser R, et al. Among authors: musso m. N Engl J Med. 2021 Jul 15;385(3):228-238. doi: 10.1056/NEJMoa2033122. N Engl J Med. 2021. PMID: 34260836 Clinical Trial.
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.
Zeiser R, von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, Szer J, Wagner EM, Zuckerman T, Mahuzier B, Xu J, Wilke C, Gandhi KK, Socié G; REACH2 Trial Group. Zeiser R, et al. N Engl J Med. 2020 May 7;382(19):1800-1810. doi: 10.1056/NEJMoa1917635. Epub 2020 Apr 22. N Engl J Med. 2020. PMID: 32320566 Clinical Trial.
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.
Wei AH, Döhner H, Pocock C, Montesinos P, Afanasyev B, Dombret H, Ravandi F, Sayar H, Jang JH, Porkka K, Selleslag D, Sandhu I, Turgut M, Giai V, Ofran Y, Kizil Çakar M, Botelho de Sousa A, Rybka J, Frairia C, Borin L, Beltrami G, Čermák J, Ossenkoppele GJ, La Torre I, Skikne B, Kumar K, Dong Q, Beach CL, Roboz GJ; QUAZAR AML-001 Trial Investigators. Wei AH, et al. N Engl J Med. 2020 Dec 24;383(26):2526-2537. doi: 10.1056/NEJMoa2004444. N Engl J Med. 2020. PMID: 33369355 Free article. Clinical Trial.
Residents Need Recess.
Musso MW, Woodward C, Crapanzano K, Bolton M, Roy M, Caffery TS. Musso MW, et al. AEM Educ Train. 2020 Aug 17;5(3):e10514. doi: 10.1002/aet2.10514. eCollection 2021 Jul. AEM Educ Train. 2020. PMID: 34027279 Free PMC article. No abstract available.
Failing Families.
Musso M. Musso M. Acad Psychiatry. 2023 Dec;47(6):597-598. doi: 10.1007/s40596-023-01886-3. Epub 2023 Oct 11. Acad Psychiatry. 2023. PMID: 37821716 No abstract available.
Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study.
Zeiser R, Russo D, Ram R, Hashmi SK, Chakraverty R, Middeke JM, Musso M, Giebel S, Uzay A, Langmuir P, Hamad N, Burock K, Gowda M, Stefanelli T, Lee SJ, Teshima T, Locatelli F. Zeiser R, et al. Among authors: musso m. J Clin Oncol. 2025 Aug 10;43(23):2566-2571. doi: 10.1200/JCO-24-02477. Epub 2025 Jun 25. J Clin Oncol. 2025. PMID: 40561385 Free PMC article. Clinical Trial.
Neuropsychological tests at the Italian Centers for Cognitive Disorders and Dementias: results from a survey on 450 specialized services.
Vaccaro R, Lorenzini P, Giaquinto F, Matascioli F, Carnevale G, Sciancalepore F, Gasparini M, Salvi E, Corbo M, Locuratolo N, Vanacore N, Bacigalupo I; Permanent Table of the National Dementia Plan Study Group; CCDDs Study Group. Vaccaro R, et al. Aging Clin Exp Res. 2024 Dec 20;37(1):1. doi: 10.1007/s40520-024-02869-6. Aging Clin Exp Res. 2024. PMID: 39704981 Free PMC article.
Nasal Irrigations: A 360-Degree View in Clinical Practice.
Pecoraro L, Di Muri E, Lezzi G, Picciolo S, De Musso M, Piazza M, Bosoni M, Indrio F. Pecoraro L, et al. Among authors: de musso m. Medicina (Kaunas). 2025 Aug 1;61(8):1402. doi: 10.3390/medicina61081402. Medicina (Kaunas). 2025. PMID: 40870447 Free PMC article. Review.
Gilteritinib in FLT3-mutated acute myeloid leukemia: A real-world Italian experience.
Cairoli R, Del Castello L, Imbergamo S, Pierdomenico E, Papayannidis C, Borlenghi E, Vetro C, Chiusolo P, Fumagalli M, Minotti C, Marchesi F, Bernardi M, Musto P, Fracchiolla N, Candoni A, Lunghi M, Musso M, Guolo F, Mannina D, Lico A, Scattolin AM, Crugnola M, Galimberti S, Nadali G, Turrini M, Zappasodi P, Todisco E, Basilico C, Grillo G, Mancini V, Riva M, Bernasconi DP, Greco R. Cairoli R, et al. Among authors: musso m. Cancer. 2025 Sep 1;131(17):e70055. doi: 10.1002/cncr.70055. Cancer. 2025. PMID: 40839405 Free PMC article.
412 results